{
    "root": "2f8bb80d-7a89-cd4d-e063-6294a90a4d87",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Memantine Hydrochloride",
    "value": "20250304",
    "ingredients": [
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "SODIUM CITRATE",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "MEMANTINE HYDROCHLORIDE",
            "code": "JY0WD0UA60"
        }
    ],
    "indications": "Memantine Hydrochloride Oral Solution is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.",
    "contraindications": "The recommended starting dose of memantine hydrochloride is 5 mg (2.5 mL) once daily. The dose should be increased in 5 mg increments to 10 mg/day (2.5 mL twice daily), 15 mg/day (2.5 mL and 5 mL as separate doses), and 20 mg/day (5 mL twice daily). The minimum recommended interval between dose increases is one week. The dosage shown to be effective in controlled clinical trials is 20 mg/day (5 mL twice daily).\n                  \n                     Dosing Titration Schedule\n                  \n                  \n                     \n                        \n                           \n                              \n                           \n                           \n                              Total daily dose\n                           \n                           \n                              Strength per dose (mg)\n                           \n                        \n                        \n                           \n                              Starting Dose\n                           \n                           \n                              5mg\n                           \n                           \n                              5mg\n                           \n                        \n                        \n                           \n                              Dose after week 1\n                           \n                           \n                              10mg\n                           \n                           \n                              5mg (first daily dose)\n                           \n                        \n                        \n                           \n                              5mg (second daily dose)\n                           \n                        \n                        \n                           \n                              Dose after week 2\n                           \n                           \n                              15mg\n                           \n                           \n                              5mg (first daily dose)\n                           \n                        \n                        \n                           \n                              10mg (second daily dose)\n                           \n                        \n                        \n                           \n                              Dose after week 3\n                           \n                           \n                              20mg\n                           \n                           \n                              10mg (first daily dose)\n                           \n                        \n                        \n                           \n                              10mg (second daily dose)\n                           \n                        \n                     \n                  \n                  Memantine hydrochloride can be taken with or without food. If a patient misses a single dose of memantine hydrochloride, that patient should not double up on the next dose. The next dose should be taken as scheduled.\n                  If a patient fails to take memantine hydrochloride for several days, dosing may need to be resumed at lower doses and retitrated as described above.\n                  Do not mix memantine hydrochloride oral solution with any other liquid. Memantine hydrochloride is administered with a syringe. A syringe should be used to withdraw the correct volume of oral solution and the oral solution should be slowly squirted into the corner of the patient’s mouth.\n                  Special Populations\n                  \n                     Renal Impairment\n                  \n                  A target dose of 5 mg (2.5 mL) twice daily is recommended in patients with severe renal impairment (creatinine clearance of 5 – 29 mL/min based on the Cockcroft-Gault equation).\n                  \n                     Hepatic Impairment\n                  \n                  Memantine hydrochloride should be administered with caution to patients with severe hepatic impairment\n \n  [see Clinical Pharmacology (\n                     \n                        12.3\n                     \n                     )].",
    "warningsAndPrecautions": "2 mg/mL Oral Solution is a clear, colorless liquid with peppermint flavor.\n                  240 mL bottle - NDC 62135-943-37\n                  Unit Dose Cup 5 mL - NDC 62135-943-05\n                  20 Unit Dose Cups of 5 mL each - NDC 62135-943-24\n                  \n                     Store memantine hydrochloride oral solution at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions": "Memantine hydrochloride is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation."
}